title: [TET2 dysregulation in hematologic malignancies].
authors.forename: Mamiko
authors.initials: M
authors.lastname: Sakata-Yanagimoto
mesh_terms: D001374:Azacitidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D003596:Cytosine / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000235:genetics* / Q000502:physiology; D000077209:Decitabine; D049308:Dioxygenases; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D044127:Epigenesis, Genetic / Q000235:genetics*; D020022:Genetic Predisposition to Disease / Q000235:genetics; D019337:Hematologic Neoplasms / Q000188:drug therapy / Q000235:genetics*; D006801:Humans; D008745:Methylation; D058990:Molecular Targeted Therapy; D005810:Multigene Family; D009154:Mutation; D009363:Neoplasm Proteins; D011518:Proto-Oncogene Proteins / Q000235:genetics* / Q000502:physiology
chemical_list: D004268:DNA-Binding Proteins; D004791:Enzyme Inhibitors; D009363:Neoplasm Proteins; D011518:Proto-Oncogene Proteins; C104746:HMC protein, human; D000077209:Decitabine; D003596:Cytosine; D049308:Dioxygenases; C541081:TET2 protein, human; D001374:Azacitidine